Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
Sponsor: University Hospital, Clermont-Ferrand
Summary
The goal of this clinical trial is to evaluate in real life, in patients with Hereditary Hemorrhagic Telangiectasia (HHT), the tolerance of the strategy of use of anticoagulant and/or antiplatelet, by comparing a new exposure period (first trimester of treatment) to a period of reference non-exposure (last trimester before start of treatment).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-04-07
Completion Date
2029-04
Last Updated
2025-04-09
Healthy Volunteers
No
Interventions
monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease
Monitoring: * hemoglobin and ferritin levels * transfusion or intravenous iron * hospitalization for bleeding or thrombose * digestive bleeding and/or another haemorrhagic accident * severity of epistaxis * quality of life
Locations (18)
CHU d'Angers
Angers, France
CHU de Bordeaux
Bordeaux, France
Hôpital Ambroise Paré
Boulogne-Billancourt, France
CHU de Caen Normandie
Caen, France
CHU clermont-ferrand
Clermont-Ferrand, France
CHU de Dijon
Dijon, France
CHRU de Lille
Lille, France
Hospices Civiles de Lyon
Lyon, France
Assistance Publique - Hôpitaux de Marseille
Marseille, France
CHU de Montpellier
Montpellier, France
CHU de Nancy
Nancy, France
CHU de Nantes
Nantes, France
CHU de Nice
Nice, France
AP-HP - Hôpital Ténon
Paris, France
CHU de Poitiers
Poitiers, France
CHU de Rennes
Rennes, France
CHRU de Strasbourg
Strasbourg, France
CHU de Toulouse
Toulouse, France